Arbor Realty raises quarterly dividend to 35c per share » 08:1307/3007/30/21
The Company announced…
The Company announced that its Board of Directors has declared a quarterly cash dividend of $0.35 per share of common stock for the quarter ended June 30, 2021, the Company's fifth consecutive quarterly increase, representing a 12.9% increase from a year ago. The dividend is payable on August 31, 2021 to common stockholders of record on August 16, 2021. The ex-dividend date is August 13, 2021.
Arbor Realty reports Q2 distributable EPS 45c, consensus 40c » 08:1207/3007/30/21
GAAP book value of…
GAAP book value of $10.97, or $11.35 per common share adjusted for $61.0 million of CECL general reserves.
Fusion Pharmaceuticals says FDA clears IND for FPI-1966 » 16:5907/2807/28/21
Fusion Pharmaceuticals announced that the U.S. FDA has cleared the company's Investigational New Drug applications for [225Ac]-FPI-1966 (FPI-1966) and imaging agent [111In]-FPI-1967 (FPI-1967). FPI-1966 is a targeted alpha therapy designed to use vofatamab, a human monoclonal antibody, to target and deliver actinium-225 to tumor sites expressing fibroblast growth factor 3, a protein that is overexpressed in multiple tumor types, particularly head and neck and bladder cancers. FPI-1966 utilizes Fusion's Fast-Clear linker to connect vofatamab to actinium-225.
new option listings on July 28th » 08:3007/2807/28/21
ACHV, ADES, ALGS, ATCX, BBCP, BTTR, CDAK, CGA, CHMI, CRCT, CRTD, DRTT, EARN, EPS, ESXB, EZM, HMLP, ICL, IMXI, INTT, LIQT, MDWD, PSJ, RTPY, SGTX, SIC, USDP, VIRI, VYGG
New option listings for…
New option listings for July 28th include Achieve Life Sciences Inc (ACHV), Advanced Emissions (ADES), Market Vectors Africa (AFK), Aligos Therapeutics Inc (ALGS), Atlas Technical Consultants Inc (Class A Stock) (ATCX), Concrete Pumping Holdings Inc (BBCP), Better Choice Company Inc (BTTR), CBX (CBX), Codiak BioSciences Inc (CDAK), China Green (CGA), Cherry Hill Mortgage (CHMI), Cricut Inc (CRCT), Creatd Inc (CRTD), WisdomTree High Dividend Fund (DHS), Dirtt Environmental Solutions Ltd (DRTT), Ellington Residential (EARN), WisdomTree SmallCap Earnings Fund (EES), WisdomTree Earnings 500 Fund (EPS), Community Bankers Trust (ESXB), WisdomTree MidCap Earnings Fund (EZM), Hoegh LNG (HMLP), IBO (IBO), Israel Chemicals (ICL), iShares Evolved US Technology ETF (IETC), iShares Edge MSCI Intl Momentum Factor ETF (IMTM), International Money Express Inc (IMXI), inTest (INTT), WisdomTree International Quality Dividend Growth Fund (IQDG), iShares Russell Top 200 (IWL), iShares Russell Top 200 Value (IWX), iShares Dow Jones US (IYY), SPDR Russell 1000 Low Volatility ETF (LGLV), LiqTech (LIQT), MediWound (MDWD), Power Shares Food And Beverage (PBJ), PowerShares S&P 500 Buy Write Portfolio (PBP), PowerShares Dynamic Media Portfolio (PBS), PowerShares FTSE RAFI Developed Markets Ex US Sm Mid Portfolio (PDN), PowerShares Dynamic Building and Construction Portfolio (PKB), PowerShares S&P SmallCap Consumer Discretionary Portfolio (PSCD), Power Shares Dynamic Software Portfolio (PSJ), Powershares Dynamic Large Cap Growth Portfolio (PWB), Powershares Dynamic Large Cap Value Portfolio (PWV), PowerShares FTSE RAFI Developed Markets ex US Portfolio (PXF), PowerShares DWA Basic Materials Momentum Portfolio (PYZ), Reinvent Technology Partners Y (Class A Stock) (RTPY), Sigilon Therapeutics Inc (SGTX), Select Interior Concepts Inc (Class A Stock) (SIC), Presidio Property Trust Inc (Class A Stock) (SQFT), USD Partners (USDP), Virios Therapeutics Inc (VIRI), Vy Global Growth (Class A Stock) (VYGG), WisdomTree Cybersecurity Fund (WCBR), Innovative Technology ETF (XITK), and SPDR NYSE Technology (XNTK).
PDS Biotechnology to present Phase 2 human clinical data » 08:1207/2807/28/21
PDS Biotechnology announced that its management team will present at several investor conferences listed below during the third quarter of 2021. At the recent American Society of Clinical Oncology 2021 Annual Meeting, interim data was presented in an oral session on PDS Biotech's lead asset, PDS0101, in combination with two investigational immune-modulating agents being studied in two groups of advanced cancer patients. In the first group of patients who had failed treatment with chemotherapy and radiation, tumor reduction was seen in 83% of patients. In the second group, patients who in addition had failed treatment with checkpoint inhibitors, tumor reduction was seen in 58% patients.
|Over a week ago|
Concrete Pumping management to meet virtually with » 12:0807/0807/08/21
Virtual Meeting to be…
Virtual Meeting to be held
Fusion Pharmaceuticals files $400M mixed securities shelf 16:2707/0207/02/21
PDS Biotechnology joins Russell Microcap Index » 08:3607/0107/01/21
PDS Biotechnology Corporation was added to the Russell Microcap Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective on June 28, according to the FTSE Russell website.
|Over a month ago|
PDS Biotechnology initiated with an Overweight at Cantor Fitzgerald » 07:1706/2806/28/21
Cantor Fitzgerald analyst…
Cantor Fitzgerald analyst Louise Chen initiated coverage of PDS Biotechnology with an Overweight rating and $25 price target. The analyst believes the peak sales potential of the company's pipeline is underappreciated. Upwards earnings revision, driven by pipeline advancements, should move the stock higher, Chen tells investors in a research note. She believes PDS has shown promising early data in both oncology and infectious diseases.
Concrete Pumping upgraded to Buy from Neutral at UBS » 06:0606/2506/25/21
UBS analyst Steven Fisher…
UBS analyst Steven Fisher upgraded Concrete Pumping to Buy from Neutral with a price target of $11, up from $6. The analyst believes that a faster than expected recovery in non-residential construction will support his "above-consensus" revenue growth and EBITDA , adding that he now sees "only a deceleration" in sales next year vs. his prior forecast of a 1%-2% decline. Concrete Pumping's leading position in the concrete pumping market is its main competitive advantage, Fisher tells investors in a research note.